Prestige Consumer Healthcare, Inc.

{
  "main_header": {
    "sid": 1159347,
    "name": "Prestige Consumer Healthcare, Inc.",
    "stock_name": "Prestige Consumer Healthcare, Inc.",
    "full_name": "Prestige Consumer Healthcare, Inc.",
    "name_url": "stocks-analysis/prestige-consumer-healthcare-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "67.73",
    "chg": 0.73,
    "chgp": "1.09%",
    "dir": 1,
    "prev_price": "67.00",
    "mcapval": "3,221.63",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US74112D1019",
    "curr_date": "Jan 22",
    "curr_time": "",
    "bse_nse_vol": "261.95 k",
    "exc_status": "Active",
    "traded_date": "Jan 22, 2026",
    "traded_date_str": "2026 01 22",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prestige-consumer-healthcare-inc-1159347-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Prestige Consumer Healthcare, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prestige-consumer-healthcares-valuation-grade-downgraded-from-attractive-to-fair-3686249",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrestigeConsume_valuationdot_3686249.png",
        "date": "2025-11-10 15:55:39",
        "description": "Prestige Consumer Healthcare, Inc. has adjusted its valuation amid shifts in financial metrics and market standing within the Pharmaceuticals & Biotechnology sector. The company displays various profitability ratios and has faced performance challenges this year, contrasting with the broader market and highlighting the competitive landscape and differing risk profiles among peers."
      },
      {
        "title": "Prestige Consumer Healthcare Stock Hits New 52-Week Low at $59.62",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prestige-consumer-healthcare-stock-hits-new-52-week-low-at-5962-3667279",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrestigeConsume_priceRelatedfactors_3667279.png",
        "date": "2025-11-03 17:06:31",
        "description": "Prestige Consumer Healthcare, Inc. has reached a new 52-week low, trading at USD 59.62 as of October 31, 2025. The company has seen a 7.75% decline over the past year, contrasting with the S&P 500's performance. Financial metrics show mixed results, with high institutional ownership and recent low quarterly sales figures."
      },
      {
        "title": "Prestige Consumer Healthcare, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prestige-consumer-healthcares-valuation-grade-downgraded-from-very-attractive-to-attractive-3667095",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PrestigeConsume_valuationdot_3667095.png",
        "date": "2025-11-03 15:53:10",
        "description": "Prestige Consumer Healthcare, Inc. has adjusted its valuation, showcasing a P/E ratio of 20 and a price-to-book value of 2.48. The company demonstrates solid profitability with a ROCE of 12.76% and ROE of 12.16%, positioning it competitively within the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Prestige Consumer Healthcare, Inc. Experiences Revision in Its Stock Evaluation Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prestige-consumer-healthcares-valuation-grade-downgraded-from-very-attractive-to-attractive-3649070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/PrestigeConsume_valuationdot_3649070.png",
        "date": "2025-10-27 15:53:58",
        "description": "Prestige Consumer Healthcare, Inc. has adjusted its valuation within the pharmaceuticals and biotechnology sector, with key metrics indicating operational efficiency and profitability. The company's performance has fluctuated, showing a decline over the past year compared to the broader market, highlighting challenges in the current environment."
      }
    ],
    "total": 16,
    "sid": "1159347",
    "stock_news_url": "https://www.marketsmojo.com/news/prestige-consumer-healthcare-inc-1159347"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Prestige Consumer Healthcare, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics

2025-11-10 15:55:39

Prestige Consumer Healthcare, Inc. has adjusted its valuation amid shifts in financial metrics and market standing within the Pharmaceuticals & Biotechnology sector. The company displays various profitability ratios and has faced performance challenges this year, contrasting with the broader market and highlighting the competitive landscape and differing risk profiles among peers.

Read full news article

Prestige Consumer Healthcare Stock Hits New 52-Week Low at $59.62

2025-11-03 17:06:31

Prestige Consumer Healthcare, Inc. has reached a new 52-week low, trading at USD 59.62 as of October 31, 2025. The company has seen a 7.75% decline over the past year, contrasting with the S&P 500's performance. Financial metrics show mixed results, with high institutional ownership and recent low quarterly sales figures.

Read full news article

Prestige Consumer Healthcare, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Landscape

2025-11-03 15:53:10

Prestige Consumer Healthcare, Inc. has adjusted its valuation, showcasing a P/E ratio of 20 and a price-to-book value of 2.48. The company demonstrates solid profitability with a ROCE of 12.76% and ROE of 12.16%, positioning it competitively within the pharmaceuticals and biotechnology sector.

Read full news article

Prestige Consumer Healthcare, Inc. Experiences Revision in Its Stock Evaluation Metrics

2025-10-27 15:53:58

Prestige Consumer Healthcare, Inc. has adjusted its valuation within the pharmaceuticals and biotechnology sector, with key metrics indicating operational efficiency and profitability. The company's performance has fluctuated, showing a decline over the past year compared to the broader market, highlighting challenges in the current environment.

Read full news article

View All News